Idera Pharmaceuticals
$0.4250
10
-$0.12-21.57% Tuesday 21:00
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
26.5M
P/E Ratio
-0.47
Dividend Yield
-
Dividend
-
Earnings
29MarExpected
Q1 2021
Q2 2021
Q3 2021
Q1 2022
Q2 2022
Q3 2022
Q4 2022
-0.21
0.75
1.7
2.66
Expected EPS
-0.12
Actual EPS
N/A
Financials
-Profit Margin
Profitable0Revenue
98.09MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Health Technology
Biotechnology
Manufacturing
Biological Product (except Diagnostic) Manufacturing
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a collaboration agreement with Bristol-Meyers Squibb. Idera Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania.
Show more...
CEO
Vincent Milano
Employees
13
Country
United States
ISIN
US45168K4058
WKN
000A2NB0G
Listings
0 Comments
Share your thoughts
FAQ
What is Idera Pharmaceuticals stock price today?▼
The current price of IDRA is $0.43 USD — it has decreased by -21.57% in the past 24 hours. Watch Idera Pharmaceuticals stock price performance more closely on the chart.
What is Idera Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Idera Pharmaceuticals stocks are traded under the ticker IDRA.
What is Idera Pharmaceuticals market cap?▼
Today Idera Pharmaceuticals has the market capitalization of 26.5M
What is Idera Pharmaceuticals revenue for the last year?▼
Idera Pharmaceuticals revenue for the last year amounts to 0 USD.
What is Idera Pharmaceuticals net income for the last year?▼
IDRA net income for the last year is 98.09M USD.
How many employees does Idera Pharmaceuticals have?▼
As of July 12, 2026, the company has 13 employees.
In which sector is Idera Pharmaceuticals located?▼
Idera Pharmaceuticals operates in the Manufacturing sector.
When did Idera Pharmaceuticals complete a stock split?▼
The last stock split for Idera Pharmaceuticals was on January 18, 2023 with a ratio of 1:17.
Where is Idera Pharmaceuticals headquartered?▼
Idera Pharmaceuticals is headquartered in Exton, United States.